SE8802193L - Utvaertes anvaendbar, antiviral farmaceutisk komposition som ackumuleras i huden samt foerfarande foer framsttaellning av densamma - Google Patents

Utvaertes anvaendbar, antiviral farmaceutisk komposition som ackumuleras i huden samt foerfarande foer framsttaellning av densamma

Info

Publication number
SE8802193L
SE8802193L SE8802193A SE8802193A SE8802193L SE 8802193 L SE8802193 L SE 8802193L SE 8802193 A SE8802193 A SE 8802193A SE 8802193 A SE8802193 A SE 8802193A SE 8802193 L SE8802193 L SE 8802193L
Authority
SE
Sweden
Prior art keywords
applicable
skin
pharmaceutical composition
procedure
preparation
Prior art date
Application number
SE8802193A
Other languages
English (en)
Other versions
SE503261C2 (sv
SE8802193D0 (sv
Inventor
A Szabolcs
L Oetvoes
J Sagi
H Tuedoes
A Szemzoe
Original Assignee
Biogal Gyogyszergyar
Mta Koezponti Kemiai Kutato In
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biogal Gyogyszergyar, Mta Koezponti Kemiai Kutato In filed Critical Biogal Gyogyszergyar
Publication of SE8802193D0 publication Critical patent/SE8802193D0/sv
Publication of SE8802193L publication Critical patent/SE8802193L/sv
Publication of SE503261C2 publication Critical patent/SE503261C2/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Oncology (AREA)
  • Dermatology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SE8802193A 1987-08-07 1988-06-13 Användning av 5-isopropyl-2'-beta-deoxyuridin för framställning av en komposition för utvärtes användning mot herpesvirus SE503261C2 (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU873596A HU196038B (en) 1987-08-07 1987-08-07 Process for producing antiherpetic pharmaceutics for external use, containing 5-isopropyl-2'-beta-deoxy-uridine

Publications (3)

Publication Number Publication Date
SE8802193D0 SE8802193D0 (sv) 1988-06-13
SE8802193L true SE8802193L (sv) 1989-02-08
SE503261C2 SE503261C2 (sv) 1996-04-29

Family

ID=10964716

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8802193A SE503261C2 (sv) 1987-08-07 1988-06-13 Användning av 5-isopropyl-2'-beta-deoxyuridin för framställning av en komposition för utvärtes användning mot herpesvirus

Country Status (25)

Country Link
US (2) US4880785A (sv)
JP (1) JPS6442437A (sv)
KR (1) KR960015953B1 (sv)
CN (1) CN1034133A (sv)
AU (1) AU605875B2 (sv)
BE (1) BE1001774A4 (sv)
CA (1) CA1286227C (sv)
CH (1) CH675538A5 (sv)
CS (1) CS276467B6 (sv)
CY (1) CY1655A (sv)
DD (1) DD270656A5 (sv)
DE (1) DE3820270A1 (sv)
DK (1) DK299088A (sv)
ES (1) ES2010559A6 (sv)
FI (1) FI883692L (sv)
FR (1) FR2619010B1 (sv)
GB (1) GB2207864B (sv)
GR (1) GR1000139B (sv)
HU (1) HU196038B (sv)
IT (1) IT1217789B (sv)
NL (1) NL8801411A (sv)
NO (1) NO882491L (sv)
RU (1) RU2035180C1 (sv)
SE (1) SE503261C2 (sv)
SG (1) SG42292G (sv)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8904855D0 (en) * 1989-03-03 1989-04-12 Beecham Group Plc Pharmaceutical treatment
ZA927277B (en) * 1991-10-02 1993-05-19 Boston Ocular Res Dry eye treatment process and solution.
DE19500784A1 (de) * 1995-01-13 1996-07-18 Bayer Ag Enrofloxacin-Injektions- oder Infusionslösungen
HUP9602024A3 (en) * 1996-07-25 1999-05-28 Toth Sandor Pharmaceutical composition containing aminoacid for external use
UA44335C2 (uk) * 1998-04-22 2002-02-15 Відкрите Акціонерне Товариство "Київмедпрепарат" Противірусний засіб "герпевір" для місцевого застосування
MY136633A (en) * 2001-01-17 2008-11-28 Berlin Chemie Ag Stabilized brivudine topical formulations

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2918260A1 (de) * 1979-05-07 1980-11-27 Robugen Gmbh Anwendung von 5-alkyl-2'-desoxyuridinen
DE3010397A1 (de) * 1980-03-18 1981-10-29 Robugen Gmbh Pharmazeutische Fabrik Esslingen A.N., 7300 Esslingen Verwendung von 5-alkyl-pyrimidinnukleosiden als cytostatika
WO1983000436A1 (en) * 1981-08-04 1983-02-17 Gauri, Kailash, Kumar Combined preparation with synergic effect
HU198393B (en) * 1984-03-06 1989-10-30 Sloan Kettering Inst Cancer Process for production of medical composition suitable for treatment of hepatitis containing as active substance derivatives of piramidin-nucleoside
HU197837B (en) * 1984-12-29 1989-06-28 Mta Koezponti Kemiai Kutato In Composition with skin cleaning effect, particularly for treating pimpled skin of face

Also Published As

Publication number Publication date
ES2010559A6 (es) 1989-11-16
CN1034133A (zh) 1989-07-26
DK299088D0 (da) 1988-06-02
CS441388A3 (en) 1992-01-15
DK299088A (da) 1989-02-08
CH675538A5 (sv) 1990-10-15
AU1741388A (en) 1989-02-09
IT8820871A0 (it) 1988-06-06
NL8801411A (nl) 1989-03-01
CY1655A (en) 1993-05-14
SE503261C2 (sv) 1996-04-29
NO882491D0 (no) 1988-06-06
FI883692A0 (fi) 1988-08-08
BE1001774A4 (fr) 1990-03-06
FR2619010B1 (fr) 1992-02-14
FR2619010A1 (fr) 1989-02-10
SG42292G (en) 1992-09-04
FI883692A7 (sv) 1989-02-08
RU2035180C1 (ru) 1995-05-20
SE8802193D0 (sv) 1988-06-13
IT1217789B (it) 1990-03-30
US4937233A (en) 1990-06-26
DE3820270A1 (de) 1989-02-16
CS276467B6 (en) 1992-06-17
JPH0515694B2 (sv) 1993-03-02
DD270656A5 (de) 1989-08-09
JPS6442437A (en) 1989-02-14
FI883692L (fi) 1989-02-08
GB8813392D0 (en) 1988-07-13
GR1000139B (el) 1991-09-27
GB2207864A (en) 1989-02-15
US4880785A (en) 1989-11-14
GR880100417A (en) 1989-05-25
KR890003380A (ko) 1989-04-14
NO882491L (no) 1989-02-08
HU196038B (en) 1988-09-28
GB2207864B (en) 1992-01-15
KR960015953B1 (ko) 1996-11-25
AU605875B2 (en) 1991-01-24
CA1286227C (en) 1991-07-16

Similar Documents

Publication Publication Date Title
ATE91233T1 (de) Antivirale pharmazeutische zusammensetzungen und ihrer verwendung.
AR240332A1 (es) Composiciones para facilitar la extraccion de articulos moldeados de poliables, composiciones de poliables que las contienen.
MY103388A (en) Azithromycin and derivatives as antiprotozoal agents
DE3763011D1 (de) Systeme zur verbesserung der durchdringungsfaehigkeit und deren zubereitung.
DE69432087D1 (de) 6-Amino-purinderivate mit PDE-IV inhibierender Wirkung
IT8620939A0 (it) Processo per la preparazione di (2,2)-paraciclofano e suoi derivati.
IT8920784A0 (it) 2 alchinilfenoli sostituiti ad azione anti infiammatoria, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono.
IT8123940A0 (it) Derivati della s-adenosilmetionina, processo per la loro preparazione e composizioni terapeutiche che licontengono come principio attivo.
ES2062292T3 (es) Un proceso para la preparacion del compuesto que tiene la estructura (7alfa,17alfa)-17-hidroxi-7-metil-19-nor-17-pregn-5(10)-in-3-ona.
DE3475714D1 (en) Griseolic acid derivatives, and their use
SE8802193D0 (sv) Externally applicable, antiviral pharmaceutical composition accumulating in the skin and process for the preparation of the same
ITRM910430A1 (it) Composizioni farmaceutiche di somatostatina con assorbimento migliorato, loro preparazione e loro impiego
MX9203642A (es) Compuestos substituidos del acido 1,3,4,9-tetrahidropirano (3,4-b)-indol-1-acetico y composiciones farmaceuticas que los contienen.
IT1197516B (it) Derivati teofillinmetilanici e teofillinmetilditianici procedimento per la loro preparazione e composizioni farmaceutiche che li comprendono
IT8320920A0 (it) Derivati di cicloalcani, procedimento per la loro preparazione e composizioni che licontengono.
ES515227A0 (es) "procedimiento para la preparacion de composiciones poliolefinicas autoextinguentes".
IT8720436A0 (it) Processo per la preparazione del 2,4-diammino-6-(1-piperidinil)-piri mi-din-n-ossido.
IT8219650A0 (it) Derivati dagli acidi alfa o beta mercaptopropionilammidoacetici, processo per la loro preparazione e composizioni terapeutiche che li comprendono come principio attivo.
IT1255471B (it) Derivati di catecolammine,processo per la loro preparazione e composizioni farmaceutiche che li contengono
BR9106596A (pt) Processo para o tratamento ou profilaxia de uma infeccao associada com retrovirus,uso,composicao farmaceutica para o tratamento ou profilaxia de uma infeccao associada com retrovirus,e,composto
EP0531537A4 (en) ANALOG OF HIRUDIN OR SALT THEREOF, THE PRODUCTION THEREOF, AND ANTICOAGULANT CONTAINING THE SAME AS AN ACTIVE INGREDIENT.
IT1207326B (it) Derivati fosforilati del cardanolo o del 3-n-pentadecilfenolo, utili come additivi per lubrificanti eprocedimento per la loro preparazione
Szabolcs et al. Method of treating herpes eye infections with 5-propyl-2'deoxyuridine.
ES8702162A1 (es) Procedimiento para preparar composiciones autoemulsionables a base de fluoroclorohidrocarburos y de esteres fosforicos
IT8420686A1 (it) "procedimenti per la preparazione di derivati del bis-idrossietilmercapto-1,10 - decano"/

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 8802193-6

Format of ref document f/p: F